Efficacy and Safety of Anti-PD1/PDL1 in Advanced Biliary Tract Cancer: A Systematic Review and Meta-Analysis

Jiang, Q; Huang, JS; Zhang, B; Li, XJ; Chen, XX; Cui, BK; Li, SP; Guo, GF

Guo, GF (通讯作者)，Sun Yat Sen Univ, VIP Dept, Canc Ctr, Guangzhou, Guangdong, Peoples R China.;Li, SP; Guo, GF (通讯作者)，Sun Yat Sen Univ, State Key Lab Oncol South China, Ctr Canc, Guangzhou, Guangdong, Peoples R China.;Li, SP; Guo, GF (通讯作者)，Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, Canc Ctr, Guangzhou, Guangdong, Peoples R China.;Li, SP (通讯作者)，Sun Yat Sen Univ, Canc Ctr, Dept Pancreaticobiliary Surg, Guangzhou, Guangdong, Peoples R China.

FRONTIERS IN IMMUNOLOGY, 2022; 13 ():

Abstract

Background: Anti-programmed cell death protein 1 and its ligand (anti-PD1/PDL1) have been proposed as a promising therapeutic option for advanced bili......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索